Search research articles
Contact Us
Filters
Showing results (171-180 of 303) with videos related to
Page
of 31
Sort By:
Cancer Medicine
|
April 19, 2022
Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors
Minsuk Kwon, Bo Mi Ku, Steve Olsen, et al.
Cancer Research and Treatment
|
March 19, 2026
Phase II Efficacy and Safety of Pembrolizumab with Platinum Based Chemotherapy in Non-Small Cell Lung Cancer Patients with Untreated, Asymptomatic Brain Metastasis (PHOEBS)
Junkyu Kim, Miran Han, Jinyong Kim, et al.
Scientific Reports
|
November 5, 2020
Regulatory (FoxP3<sup>+</sup>) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Jiae Koh, Joon Young Hur, Kyoung Young Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 15, 2016
Two Cases of Small Cell Lung Cancer Transformation from EGFR Mutant Adenocarcinoma During AZD9291 Treatment
Jun Soo Ham, Seokhwi Kim, Hee Kyung Kim, et al.
Cancer Research and Treatment
|
July 28, 2018
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
Seonggyu Byeon, Youjin Kim, Sung Won Lim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
August 10, 2024
Comparison of the treatment outcomes of different neoadjuvant chemoradiotherapy regimens for resectable locally advanced esophageal cancer
Hyunki Park, Kyungmi Yang, Jae Myoung Noh, et al.
Expert Opinion on Investigational Drugs
|
August 1, 2020
Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumors
Seokuee Kim, Sujong Kim, Young Suk Park, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 31, 2011
Expression of excision repair cross-complementation group 1 as predictive marker for nasopharyngeal cancer treated with concurrent chemoradiotherapy
Jong-Mu Sun, Myung-Ju Ahn, Min Jae Park, et al.
JAMA Network Open
|
March 17, 2023
Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020
Sang Ah Chi, Hyeyeon Yu, Yoon-La Choi, et al.
BMC Cancer
|
May 24, 2012
ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy
Jong-Mu Sun, Ji-Youn Sung, Se Hoon Park, et al.
Page
of 31
Search research articles
Search
Showing results (171-180 of 303) with videos related to
Sort By:
Page
of 31
Cancer Medicine
|
April 19, 2022
Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors
Minsuk Kwon, Bo Mi Ku, Steve Olsen, et al.
Cancer Research and Treatment
|
March 19, 2026
Phase II Efficacy and Safety of Pembrolizumab with Platinum Based Chemotherapy in Non-Small Cell Lung Cancer Patients with Untreated, Asymptomatic Brain Metastasis (PHOEBS)
Junkyu Kim, Miran Han, Jinyong Kim, et al.
Scientific Reports
|
November 5, 2020
Regulatory (FoxP3<sup>+</sup>) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Jiae Koh, Joon Young Hur, Kyoung Young Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 15, 2016
Two Cases of Small Cell Lung Cancer Transformation from EGFR Mutant Adenocarcinoma During AZD9291 Treatment
Jun Soo Ham, Seokhwi Kim, Hee Kyung Kim, et al.
Cancer Research and Treatment
|
July 28, 2018
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
Seonggyu Byeon, Youjin Kim, Sung Won Lim, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
August 10, 2024
Comparison of the treatment outcomes of different neoadjuvant chemoradiotherapy regimens for resectable locally advanced esophageal cancer
Hyunki Park, Kyungmi Yang, Jae Myoung Noh, et al.
Expert Opinion on Investigational Drugs
|
August 1, 2020
Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumors
Seokuee Kim, Sujong Kim, Young Suk Park, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 31, 2011
Expression of excision repair cross-complementation group 1 as predictive marker for nasopharyngeal cancer treated with concurrent chemoradiotherapy
Jong-Mu Sun, Myung-Ju Ahn, Min Jae Park, et al.
JAMA Network Open
|
March 17, 2023
Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020
Sang Ah Chi, Hyeyeon Yu, Yoon-La Choi, et al.
BMC Cancer
|
May 24, 2012
ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy
Jong-Mu Sun, Ji-Youn Sung, Se Hoon Park, et al.
Page
of 31